Barliso, Pearl Michell .
HRN: 28-47-15 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2026
CEFUROXIME 500MG (TAB)
05/11/2026
05/18/2026
ORAL
500mg
BID
S/P NSVD With Perineorrhaphy
Checking Initial Appropriateness